Peter Lynch fit · Growth at a reasonable price (GARP)
Is West Pharmaceutical Services, Inc. (WST) a Peter Lynch Stock?
Does not fit Lynch's GARP criteria - growth too low or price too high.
24/100
FNot a fit
3/6 criteria passed
+8 sector-quality lift. Top-quintile within its sector on 4 of 5 quality metrics. Raw pillar score 16 → lifted to 24 before grade derivation.
Peter Lynch's Criteria, Applied to WST
PEG ≤ 1.0
key-
EPS CAGR ≥ 15%
key-6.4%
Revenue CAGR ≥ 10%
2.1%
Net margin > 0
16.9%
How WST Scores on Other Strategies
Live Financial Snapshot
Market cap
$24.37B
P/E (TTM)
39.8x
ROIC (TTM)
15.24%
Gross margin
36.24%
Other Peter Lynch fit reports
Frequently Asked Questions
What is WST's Peter Lynch fit score?
WST scores 24/100 on our Peter Lynch fit engine - grade F. Does not fit Lynch's GARP criteria - growth too low or price too high.
Does Peter Lynch actually own WST?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends WST.
How often is this score updated?
WST's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends WST.